Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Annalucia Carbone is active.

Publication


Featured researches published by Annalucia Carbone.


International Journal of Pharmaceutics | 2013

Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles

Adriana Trapani; Sante Di Gioia; Nicoletta Ditaranto; Nicola Cioffi; Francisco M. Goycoolea; Annalucia Carbone; Marcos Garcia-Fuentes; Massimo Conese; María J. Alonso

The aim of this study was to evaluate the performance of chitosan (CS) and glycol chitosan (GCS) nanoparticles containing the surfactant Lipoid S100 for the systemic delivery of low molecular weight heparin (LMWH) upon pulmonary administration. These nanoparticles were prepared in acidic and neutral conditions using the ionotropic gelation technique. The size and zeta potential of the NPs were affected by the pH and also the type of polysaccharide (CS or GCS). The size (between 156 and 385 nm) was smaller and the zeta potential (from +11 mV to +30 mV) higher for CS nanoparticles prepared in acidic conditions. The encapsulation efficiency of LMWH varied between 100% and 43% for the nanoparticles obtained in acidic and neutral conditions, respectively. X-ray photoelectron spectroscopy studies indicated that the surfactant Lipoid S100 was localized on the nanoparticles surface irrespective of the formulation conditions. In vivo studies showed that systems prepared in acidic conditions did not increase coagulation times when administered to mice by the pulmonary route. In contrast, Lipoid S100-LMWH GCS NPs prepared in neutral conditions showed a pharmacological efficacy. Overall, these results illustrate some promising features of CS-based nanocarriers for pulmonary delivery of LMWH.


The Scientific World Journal | 2014

Hematopoietic and Mesenchymal Stem Cells for the Treatment of Chronic Respiratory Diseases: Role of Plasticity and Heterogeneity

Massimo Conese; Donatella Piro; Annalucia Carbone; Stefano Castellani; Sante Di Gioia

Chronic lung diseases, such as cystic fibrosis (CF), asthma, and chronic obstructive pulmonary disease (COPD) are incurable and represent a very high social burden. Stem cell-based treatment may represent a hope for the cure of these diseases. In this paper, we revise the overall knowledge about the plasticity and engraftment of exogenous marrow-derived stem cells into the lung, as well as their usefulness in lung repair and therapy of chronic lung diseases. The lung is easily accessible and the pathophysiology of these diseases is characterized by injury, inflammation, and eventually by remodeling of the airways. Bone marrow-derived stem cells, including hematopoietic stem/progenitor cells (HSPCs) and mesenchymal stromal (stem) cells (MSCs), encompass a wide array of cell subsets with different capacities of engraftment and injured tissue regenerating potential. Proof-of-principle that marrow cells administered locally may engraft and give rise to specialized epithelial cells has been given, but the efficiency of this conversion is too limited to give a therapeutic effect. Besides the identification of plasticity mechanisms, the characterization/isolation of the stem cell subpopulations represents a major challenge to improving the efficacy of transplantation protocols used in regenerative medicine for lung diseases.


Journal of Gene Medicine | 2012

Lentiviral small hairpin RNA delivery reduces apical sodium channel activity in differentiated human airway epithelial cells

Jamil Aarbiou; Elena Copreni; Ruvalic M. Buijs-Offerman; Pascal van der Wegen; Stefano Castellani; Annalucia Carbone; Francesca Tilesi; Piera Assunta Fradiani; Pieter S. Hiemstra; Guelnihal Yueksekdag; Anna Diana; Joseph Rosenecker; Fiorentina Ascenzioni; Massimo Conese; Bob J. Scholte

Epithelial sodium channel (ENaC) hyperactivity has been implicated in the pathogenesis of cystic fibrosis (CF) by dysregulation of fluid and electrolytes in the airways. In the present study, we show proof‐of‐principle for ENaC inhibition by lentiviral‐mediated RNA interference.


Histology and Histopathology | 2016

Emerging relationship between CFTR, actin and tight junction organization in cystic fibrosis airway epithelium

Stefano Castellani; Maria Favia; Lorenzo Guerra; Annalucia Carbone; Anna Claudia Abbattiscianni; Sante Di Gioia; Valeria Casavola; Massimo Conese

Cystic fibrosis (CF), one of the most common genetic disorders affecting primarily Caucasians, is due to mutations in the CF Transmembrane Conductance Regulator (CFTR) gene, encoding for a chloride channel also acting as regulator of other transmembrane proteins. In healthy subjects, CFTR is maintained in its correct apical plasma membrane location via the formation of a multiprotein complex in which scaffold proteins (such as NHERF1) and signaling molecules (such as cAMP and protein kinases) guarantee its correct functioning. In CF, a disorganized and dysfunctional airway epithelium brings an altered flux of ions and water into the lumen of bronchioles, consequent bacterial infections and an enormous influx of inflammatory cells (mainly polymorphonuclear neutrophils) into the airway lumen. Recent evidence in healthy airway cells supports the notion that CFTR protein/function is strictly correlated with the actin cytoskeleton and tight junctions status. In CF cells, the most frequent CFTR gene mutation, F508del, has been shown to be associated with a disorganized actin cytoskeleton and altered tight junction permeability. Thus, the correct localization of CFTR on the apical plasma membrane domain through the formation of the scaffolding and signaling complex is likely fundamental to determine a physiological airway epithelium. The correction of CFTR mutations by either gene or drug therapies, as well as by stem cell-based interventions, can determine the resumption of a physiological organization of actin stress fibers and TJ structure and barrier function, further indicating the close interrelationship among these processes.


Current Drug Delivery | 2016

From Genesis To Revelation: The Role Of Inflammatory Mediators In Chronic Respiratory Diseases And Their Control By Nucleic Acid-Based Drugs.

Sante Di Gioia; Carla Sardo; Stefano Castellani; Barbara Porsio; Giuliana Belgiovine; Annalucia Carbone; Gaetano Giammona; Gennara Cavallaro; Massimo Conese

Asthma, chronic obstructive pulmonary disease, cystic fibrosis, and idiopathic pulmonary fibrosis, are among the most common chronic diseases and their prevalence is increasing. Each of these diseases is characterized by the secretion of cytokines and pro-inflammatory molecules which are thought to play a critical role in their pathogenesis. Moreover, immune cells, particularly neutrophils, macrophages and dendritic cells as well structural cells such as epithelial and airway smooth muscle cells are also involved in the pathogenic cycle of these diseases. There is a pressing need for the development of new therapies for these pulmonary diseases, particularly as no existing treatment has been shown to reduce disease progression. HMGB1 (high-mobility group box 1), originally identified as a nuclear non histone protein with DNA-binding domains can be secreted by living and dying cells and it is now regarded as an important endogenous danger signaling molecule. Besides as a signal of tissue injury, HMGB1 is considered a powerful mediator of inflammation and high levels of HMGB1 are found in chronic lung diseases. The role of HMGB1 in respiratory diseases is still elusive nevertheless these studies suggest an involvement of this cytokine in their pathogenesis. Nucleic acid-based drugs (NABDs) are a novel class of pharmaceuticals including antisense oligonucleotides, DNA-zymes, and RNA interference as mediated by small interfering RNA (siRNA), which are used to dampen the expression of disease-causing genes having therapeutic potential for controlling chronic airway diseases. Due to their inherent difficulties, such as for example sensitivity to endonucleases, their delivery in vivo should be assured by vectors. Non-viral lipid- and polymer-based nanosystems have acquired much importance in this context. In this review, we will discuss these emerging tools in gene therapy of chronic lung diseases, particularly the use of siRNA in the down-regulation of critical molecules in the pathogenesis of chronic lung diseases, with particular emphasis on HMGB1 as therapeutic target.


Experimental Cell Research | 2016

Human airway epithelial cells investigated by atomic force microscopy: A hint to cystic fibrosis epithelial pathology.

Maria Lasalvia; Stefano Castellani; Palma D’Antonio; Giuseppe Perna; Annalucia Carbone; Anna Laura Colia; Angela Bruna Maffione; Vito Capozzi; Massimo Conese

The pathophysiology of cystic fibrosis (CF) airway disease stems from mutations in the CF Transmembrane Conductance Regulator (CFTR) gene, leading to a chronic respiratory disease. Actin cytoskeleton is disorganized in CF airway epithelial cells, likely contributing to the CF-associated basic defects, i.e. defective chloride secretion and sodium/fluid hypersorption. In this work, we aimed to find whether this alteration could be pointed out by means of Atomic Force Microscopy (AFM) investigation, as roughness and Youngs elastic module. Moreover, we also sought to determine whether disorganization of actin cytoskeleton is linked to hypersoption of apical fluid. Not only CFBE41o- (CFBE) cells, immortalized airway epithelial cells homozygous for the F508del CFTR allele, showed a different morphology in comparison with 16HBE14o- (16HBE) epithelial cells, wild-type for CFTR, but also they displayed a lack of stress fibers, suggestive of a disorganized actin cytoskeleton. AFM measurements showed that CFBE cells presented a higher membrane roughness and decreased rigidity as compared with 16HBE cells. CFBE overexpressing wtCFTR became more elongated than the parental CFBE cell line and presented actin stress fibers. CFBE cells absorbed more fluid from the apical compartment. Study of fluid absorption with the F-actin-depolymerizing agent Latrunculin B demonstrated that actin cytoskeletal disorganization increased fluid absorption, an effect observed at higher magnitude in 16HBE than in CFBE cells. For the first time, we demonstrate that actin cytoskeleton disorganization is reflected by AFM parameters in CF airway epithelial cells. Our data also strongly suggest that the lack of stress fibers is involved in at least one of the early step in CF pathophysiology at the levels of the airways, i.e. fluid hypersorption.


Open Medicine | 2017

The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation

Massimo Conese; Annalucia Carbone; Elisa Beccia; Antonella Angiolillo

Abstract Transfusion (or drinking) of blood or of its components has been thought as a rejuvenation method since ancient times. Parabiosis, the procedure of joining two animals so that they share each others blood circulation, has revitalized the concept of blood as a putative drug. Since 2005, a number of papers have reported the anti-ageing effect of heterochronic parabiosis, which is joining an aged mouse to a young partner. The hallmark of aging is the decline of regenerative properties in most tissues, partially attributed to impaired function of stem and progenitor cells. In the parabiosis experiments, it was elegantly shown that factors derived from the young systemic environment are able to activate molecular signaling pathways in hepatic, muscle or neural stem cells of the old parabiont leading to increased tissue regeneration. Eventually, further studies have brought to identify some soluble factors in part responsible for these rejuvenating effects, including the chemokine CCL11, the growth differentiation factor 11, a member of the TGF-β superfamily, and oxytocin. The question about giving whole blood or specific factors in helping rejuvenation is open, as well as the mechanisms of action of these factors, deserving further studies to be translated into the life of (old) human beings.


Cells Tissues Organs | 2013

Contents Vol. 197, 2013

Diego A. Vargas; Oliver Bates; Muhammad H. Zaman; Carola B. Bozal; Luciana M. Sánchez; Patricia Mandalunis; Angela M. Ubios; Ke Xue; Lin Qi; Guangdong Zhou; Kai Liu; Jin Wu; Berton R. Moed; Margaret Thorpe; Lew C. Schon; Zijun Zhang; Massimo Conese; Annalucia Carbone; Stefano Castellani; Sante Di Gioia; Nur Akmarina B.M. Said; Kaylene J. Simpson; Elizabeth D. Williams; Donald F. Newgreen; Erik W. Thompson; J. Tracy Watson; Teresa Foo; Satz Mengensatzproduktion; Druck Reinhardt Druck Basel

Founded 1945 as ‘Acta Anatomica’ by R. Chambers, G. Glimstedt, T. Peterfi and G. Wolf-Heidegger Continued 1962–1974 by E.A. Boyden, 1955–1980 by A. Delmas, 1972–1980 by F. Walberg, 1945–1980 by G. Wolf-Heidegger, 1981–1988 by R. O’Rahilly, Davis, Calif., 1989–1990 by G.E. Goslow, Jr., Providence, R.I., 1981–1992 by W. Lierse, Hamburg, since 1992 by H.-W. Denker, Essen, and A.W. English, Atlanta, Ga., continued 1999 as ‘Cells Tissues Organs’ by H.-W. Denker, Essen, and A.W. English, Atlanta, Ga.


Plastic and reconstructive surgery. Global open | 2018

A New Integrated Approach for the Treatment of Complicated Ulcers

Liberato Cecchino; Luigi Annacontini; Fedele Lembo; Massimo Conese; Annalucia Carbone; Domenico Parisi; Aurelio Portincasa


VIII Meeting Steam Cell Research Italy | 2017

Gap junctions are involved in the rescue of CFTR-dependent chloride efflux by amniotic mesenchymal stem cells in co-culture with cystic fibrosis CFBE41o- cells

Elisa Beccia; Annalucia Carbone; Maria Favia; Roberto Zefferino; Stefano Castellani; Antonella Angiolillo; Valeria Casavola; Massimo Conese

Collaboration


Dive into the Annalucia Carbone's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carla Colombo

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Manuela Seia

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Researchain Logo
Decentralizing Knowledge